JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:1924-1930, doi:10.1016/j.jacc.2007.01.081 (Published online 30 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Related Collections
Right arrowRelated Article

Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)

Maurizio Menichelli, MD*,*, Antonio Parma, MD*, Edoardo Pucci, MD*, Rosario Fiorilli, MD*, Francesco De Felice, MD*, Marco Nazzaro, MD*, Alessia Giulivi, MD*, Domenico Alborino, MD*, Arianna Azzellino, PhD{dagger} and Roberto Violini, MD*

* Division of Interventional Cardiology, San Camillo Hospital, Rome, Italy
{dagger} Politecnico Milano, Milan, Italy.


Figure 1
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 CONSORT Diagram of the Study

BMS = bare-metal stents; CONSORT = Consolidated Standards of Reporting Trials; SES = sirolimus-eluting stents.

 

Figure 2
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Actuarial Rate of Survival Free From TLR and TVF Among Patients Who Received an SES or a BMS

The rate of event-free survival was significantly higher in the sirolimus-eluting stent (SES) group. BMS = bare-metal stent; TLR = target lesion revascularization; TVF = target vessel failure.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.